Results 231 to 240 of about 34,133,693 (246)

Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2Receptor Agonists

Chemical Reviews, 2016
Mojgan Aghazadeh Tabrizi, Pier Andrea Borea, Katia Varani   +2 more
exaly  

Pharmacological comparison of muscarinic ligands: Historical versus more recent muscarinic M1-preferring receptor agonists

European Journal of Pharmacology, 2009
John A Butera
exaly  

Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes: Differences and similarities

European Journal of Internal Medicine, 2014
Tina VILSBØLL, Filip K Knop, Asger Lund   +2 more
exaly  

Effect of Glucagon-like Peptide-1 Receptor Agonists on Lipid Profiles Among Type 2 Diabetes: A Systematic Review and Network Meta-analysis

Clinical Therapeutics, 2015
Linong Ji, Jing Wang
exaly  

Development of High Affinity Selective VIP1 Receptor Agonists

Peptides, 1997
Magali Waelbroeck, P Robberecht, P Gourlet   +2 more
exaly  

Discovery of a new series of 5-HT1A receptor agonists

Bioorganic and Medicinal Chemistry Letters, 2010
Claudia Sorbi, Paola Fossa, Livio Brasili   +2 more
exaly  

Interaction of benzodiazepine receptor agonists and inverse agonists with the GABA benzodiazepine receptor complex

Pharmacology Biochemistry and Behavior, 1985
M Karobath
exaly  

The safety and tolerability of GLP‐1 receptor agonists in the treatment of type 2 diabetes: a review

Diabetes/Metabolism Research and Reviews, 2011
Vanita Aroda
exaly  

Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration

Brain Research Bulletin, 2014
Mrinmay Chakrabarti, Mitzi Nagarkatti, Azizul Haque   +2 more
exaly  

Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy

European Journal of Pharmacology, 1990
Peter H Andersen, P H Andersen
exaly